PRE 14C

PRELIMINARY PROXY STATEMENT

Company: Sunshine Biopharma Inc.
Filed: June 8, 2015
Period of Report: June 8, 2015
Accession Number: 0001354488-15-002881

View Document ↗ View on SEC.gov ↗